15 October 2021: Clinical Research
The Serum Metabolomics Study of Liver Failure and Artificial Liver Therapy Intervention
Shipeng Huang 1ABC , Dali Hu 2BCD , Songsong Yuan 2BCD , Ying He 2BCD , Chengmu Li 2BCD , Ying Zhu 2BCD , Xiaoping Wu 2AEF*DOI: 10.12659/MSM.930638
Med Sci Monit 2021; 27:e930638
Table 2 Comparison of laboratory data of patients with liver failure before and after artificial liver treatment.
| Target | Before artificial liver therapy | Artificial liver therapy | t/Z value | P value |
|---|---|---|---|---|
| ALT (U/L) | 676.6±699.3 | 345.2±335.6 | 1.65 | 0.109 |
| AST (U/L) | 501.8±503.6 | 203.1±170.0 | 2.18 | 0.038 |
| TBIL (mmol/L) | 297.0±73.6 | 152.3±41.2 | 6.65 | |
| DBIL (mmol/L) | 181.1±51.8 | 88.7±31.9 | 5.88 | |
| ALB(g/L) | 30.4±4.1 | 29.0±3.1 | 1.05 | 0.304 |
| The results were expressed as mean±standard deviation, and P | ||||